Concepedia

Joseph G. Jurcic

JG

Statistics

Publications

70

Citations

9.7K

H-Index

41

Active since

1995

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Columbia University Irving Medical Center

Cornell University

The University of Texas MD Anderson Cancer Center

Northwestern University

Joseph G. Jurcic is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and hematologic malignancy therapy.

Publications per year

1995–2023

70

Publications

70

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia

Renier J. Brentjens, Marco L. Davila, Isabelle Rivière et al. · Science Translational Medicine · 2013 · 2.1K citations · Full text

Life Sciences, Immunology, Oncology +13

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Renier J. Brentjens, Isabelle Rivière, Jae H. Park et al. · Blood · 2011 · 1.3K citations · Full text

Medicine, Immunology, Oncology +11

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti et al. · New England Journal of Medicine · 2020 · 537 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes et al. · The Lancet Oncology · 2017 · 488 citations · Full text

Medicine, Oncology, Pharmacology +10

Targeted α particle immunotherapy for myeloid leukemia

Joseph G. Jurcic, Steven M. Larson, George Sgouros et al. · Blood · 2002 · 467 citations · Full text

Medicine, Hematology, Oncology +14

1–5 of 70